ABVC BioPharma, Inc. (ABVC) Operating cash flow 2017–2025
ABVC BioPharma, Inc. (ABVC) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$3.0MFY2025 · since FY2017: -$1.5M → -$3.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$3.0M | -65.1% |
| FY2024 | -$1.8M | +56.8% |
| FY2023 | -$4.2M | +43.4% |
| FY2022 | -$7.4M | +2.6% |
| FY2021 | -$7.6M | -66.5% |
| FY2020 | -$4.6M | -45.6% |
| FY2019 | -$3.1M | -248.1% |
| FY2018 | -$900,531 | +39.4% |
| FY2017 | -$1.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice